What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cardiology
Internal medicine, Endocrinology, Cholesterol, Cardiology and Lipoprotein are his primary areas of study.
His Internal medicine study integrates concerns from other disciplines, such as Diabetes mellitus and Placebo.
His research integrates issues of Proinflammatory cytokine, Blood viscosity and Bioinformatics in his study of Endocrinology.
His Cholesterol study incorporates themes from Pharmacotherapy and Risk factor.
His Cardiology study combines topics from a wide range of disciplines, such as Expert consensus and Mass screening.
His Lipoprotein research integrates issues from Inflammation, Low-density lipoprotein and Pharmacology.
His most cited work include:
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association (1995 citations)
- Antiatherothrombotic Properties of Statins Implications for Cardiovascular Event Reduction (907 citations)
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension (853 citations)
What are the main themes of his work throughout his whole career to date?
Robert S. Rosenson spends much of his time researching Internal medicine, Endocrinology, Cardiology, Statin and Cholesterol.
He combines topics linked to Diabetes mellitus with his work on Internal medicine.
The study incorporates disciplines such as Residual risk and Aspirin in addition to Diabetes mellitus.
His work on Blood viscosity as part of general Cardiology research is frequently linked to In patient, thereby connecting diverse disciplines of science.
His study explores the link between Statin and topics such as Intensive care medicine that cross with problems in Disease.
The Cholesterol study combines topics in areas such as Coronary artery disease, Vascular disease, Pharmacology and Bioinformatics.
He most often published in these fields:
- Internal medicine (68.87%)
- Endocrinology (27.01%)
- Cardiology (22.68%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (68.87%)
- Statin (23.30%)
- Dyslipidemia (10.31%)
In recent papers he was focusing on the following fields of study:
Robert S. Rosenson focuses on Internal medicine, Statin, Dyslipidemia, Misinformation and In patient.
The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Cardiology.
Robert S. Rosenson has included themes like Arterial disease and Disease in his Cardiology study.
His work in Statin covers topics such as Intensive care medicine which are related to areas like Thrombosis and Inflammation.
His Dyslipidemia study also includes
- Low density lipoprotein cholesterol that intertwine with fields like Statin therapy,
- Evolocumab that connect with fields like Placebo, Type 2 diabetes, Monoclonal and Randomized controlled trial,
- Clinical trial which is related to area like Coronary artery disease.
Robert S. Rosenson mostly deals with Lipoprotein in his studies of Endocrinology.
Between 2018 and 2021, his most popular works were:
- Deep learning for cardiovascular medicine: a practical primer. (62 citations)
- Evinacumab for Homozygous Familial Hypercholesterolemia (51 citations)
- Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials. (44 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cardiology
His primary areas of study are Internal medicine, Statin, Cholesterol, Diabetes mellitus and Cardiology.
Robert S. Rosenson interconnects Placebo and Evolocumab in the investigation of issues within Internal medicine.
Robert S. Rosenson has researched Statin in several fields, including Dyslipidemia, Pharmacotherapy, Retrospective cohort study and Intensive care medicine.
His studies in Cholesterol integrate themes in fields like Gastroenterology and Disease.
His research integrates issues of Endocrinology and Familial hypercholesterolemia in his study of Disease.
His Diabetes mellitus study combines topics in areas such as Quality of care, Aspirin and Reduction.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
